© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Fellows' Corner
7-Tesla MRI Use in Research: Jemima Akinsanya, DO, and Daniel Reich, MD, PhD
March 31, 2021
The duo from the National Institutes of Health discussed the advantages of the ultra-high resolution imaging technology in research.
Studies of Anakinra and Tolebrutinib in MS Paramagnetic Rim Lesions: Jemima Akinsanya, DO
March 24, 2021
The Neuroimmunology Clinical Fellow at the National Institutes of Health discussed the evaluations of 2 therapies in multiple sclerosis that she is partaking in.
Investigating Causes of CNS Demyelination: Spencer Hutto, MD
March 17, 2021
The fellow of autoimmune neurology at Massachusetts General Hospital discussed the need for follow-up with patients long-term after TNFα inhibitor treatment.
High Rates of MS Relapse after TNFα Inhibitor Discontinuation: Spencer Hutto, MD
March 03, 2021
The fellow of autoimmune neurology at Massachusetts General Hospital discusses the ongoing question about whether the demyelination is an unmasking of disease or consequence of the treatment.
Investigating TNFα Inhibition and CNS Demyelination: Spencer Hutto, MD
February 26, 2021
The fellow of autoimmune neurology at Massachusetts General Hospital discussed the analysis his team conducted to clarify the known associations.
Health-Deficit Accumulation Affects Risk for Mild Cognitive Impairment, Dementia
November 17, 2020
Frailty index score can identify patients at risk for cognitive dysfunction and might be an important marker with potential prognostic value.
Davide Valeriani, PhD: Using the DystoniaNet Platform for Dystonia Diagnosis
October 06, 2020
The postdoctoral research fellow in the Dystonia and Speech Motor Control Laboratory at Mass Eye and Ear spoke to the clinical translation of the AI-based DystoniaNet tool.
Leah Croll, MD: Importance of Mental Health of Clinicians During COVID-19 Pandemic
September 24, 2020
The neurology resident at NYU Langone shared her thoughts on the need for publication of clinician-based data and why maintaining a high level of mental health remains a top priority during the COVID-19 pandemic.
Neurology Residency Training During a Pandemic
September 16, 2020
In part 2 of this interview, Leah Croll, MD, a neurology resident on the front lines of the COVID-19 pandemic, describes how her resident program experience was impacted by the pandemic.
The Psychosocial Impact of COVID-19 in Neurology Departments
September 10, 2020
Leah Croll, MD, a neurology resident on the front lines of the COVID-19 pandemic, shares details from her study on the psychosocial impact on physicians and her first-hand experience.
Leah Croll, MD: Psychosocial Implications of COVID-19 on Doctors
September 08, 2020
The neurology resident at NYU Langone described psychosocial implications that physicians faced during the COVID-19 pandemic and the toll it takes on them.
Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical Care
August 12, 2020
The postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.
Q&A: Genetic Ancestry and Alzheimer Disease Risk
August 06, 2020
Katrina Celis, MD, a postdoctoral fellow at the University of Miami Miller School of Medicine, discussed how ancestral genetics can play a key role in Alzheimer disease risk.
Katrina Celis, MD: Ancestral Genetics and the Impact on Alzheimer Disease Risk
August 01, 2020
The postdoctoral fellow at the University of Miami Miller School of Medicine detailed her study presented at AAIC 2020 that examined Alzheimer risk associated with APOE ε4 in different genetic populations.
Fred Cohen, MD: OnabotulinumtoxinA and CGRP Combination Treatment
July 15, 2020
The internal medicine resident physician at Montefiore Health System provided an overview of the study he and colleagues conducted on patients using onabotulinumtoxinA and CGRP agents in tandem.
Episode 12: Masculinity and Multiple Sclerosis
June 26, 2020
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Bryan Davis, PsyD, MS.
Fred Cohen, MD: Combining CGRPs and OnabotulinumtoxinA for Migraine Prevention
June 22, 2020
The internal medicine resident physician at Montefiore Health System offers insight into the combined use of CGRP medications and Botox to optimize migraine prevention in patients who have inadequate response with Botox alone.
The Long-Term Impact of Addressing Gender Norms for Men With MS
June 18, 2020
In Part 2 of this interview, Bryan Davis, PsyD, MS, clinical health psychology fellow at Cleveland Clinic’s Mellen Center for MS, details the impact that conversations about masculinity norms in MS can have on future trials and care.
Bryan Davis, PsyD, MS: Future Discussion on Masculinity Norms in MS
June 16, 2020
The clinical health psychology fellow at Cleveland Clinic’s Mellen Center for MS Treatment and Research at Cleveland Clinic details the interventions for men with MS and how the study can change the discussion on masculinity norms.
Why Learning About Masculine Norms Can Improve MS Care
June 13, 2020
In Part 1 of this interview, the clinical health psychology fellow at Cleveland Clinic’s Mellen Center for MS Treatment and Research provides in-depth insight on his study evaluating masculinity norms in patients with multiple sclerosis.